Trial intelligence / Profile preview

rIFN-gamma 1b in Acute Cryptococcal Meningitis

NCT00012467Phase 2Completed

Sponsor
InterMune
Start
Jan 2000
Modality
Cytokines & Interferons
Countries
2
01

Overview

A Phase 2 trial of interferon gamma-1b in cryptococcal meningitis, sponsored by InterMune. Started Jan 2000; status: completed.

02

Drugs

interferon gamma-1b
03

Conditions

cryptococcal meningitis

Beyond the preview

Go deeper on NCT00012467.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00012467.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call